Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 1, 2020
- Accepted December 9, 2020
- Published online January 8, 2021.
Copyright & Usage
Copyright ©ERS 2021 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Imre Noth1,
- Vincent Cottin2,
- Nazia Chaudhuri3,
- Tamera J Corte4,5,
- Kerri A Johannson6,
- Marlies Wijsenbeek7,
- Stephane Jouneau8,
- Andreas Michael9,
- Manuel Quaresma10,
- Klaus B Rohr10,
- Anne-Marie Russell11,
- Susanne Stowasser10 and
- Toby M Maher12,13,14
- on behalf of the INMARK trial investigators
- 1Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia, USA
- 2National Reference Centre for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France
- 3North West Interstitial Lung Disease Unit, Manchester University Foundation Trust, Wythenshawe, Manchester, UK
- 4Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
- 5Australia and University of Sydney, New South Wales, Australia
- 6Medicine & Community Health Sciences, University of Calgary, Calgary, Canada
- 7Department of Respiratory Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands
- 8Hôpital Pontchaillou - CHU de Rennes, IRSET UMR 1085, Université de Rennes 1, Rennes, France
- 9Syneos Health, Farnborough, UK
- 10Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
- 11College of Medicine and Health University of Exeter, Exeter, UK
- 12National Heart and Lung Institute, Imperial College London, London, UK
- 13National Institute for Health Research Clinical Research Facility, Royal Brompton Hospital, London, UK
- 14Keck School of Medicine, University of Southern California, Los Angeles, California, USA
- Prof Toby M Maher, National Heart and Lung Institute, Imperial College, London, UK. E-mail: t.maher{at}rbht.nhs.uk
Funding
Boehringer Ingelheim
Article usage
Altmetrics
Vol 57 Issue 1
Table of Contents
Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial
